Jhund PS, MacIntyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, Chalmers JWT, Capewell S, McMurray JJV: Long-term trends in first hospitalisation for heart failure and subsequent survival between 1986 and 2003. A population study of 5.1 million people. Circulation. 2009, 119: 515-523. 10.1161/CIRCULATIONAHA.108.812172.
Article
PubMed
Google Scholar
Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KKL, Murabito JM, Vasan RS: Long-term trends in the incidence of and survival with heart failure. New England J Med. 2002, 347 (18): 1397-1402. 10.1056/NEJMoa020265.
Article
Google Scholar
Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ: Trends in heart failure incidence and survival in a community-based population. JAMA. 2004, 292 (3): 344-350. 10.1001/jama.292.3.344.
Article
PubMed
CAS
Google Scholar
Bleumink GS, Knetsch AM, Sturkenboom MCJM, Straus SM, Hofman A, Deckers JW, Witteman JCM, Stricker BH: Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J. 2004, 25 (18): 1614-1619. 10.1016/j.ehj.2004.06.038.
Article
PubMed
Google Scholar
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, and on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics--2013 update a report from the American heart association. Circulation. 2013, DOI: 10.1161/CIR.0b013e31828124ad
Google Scholar
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, for the U.S. Carvedilol Heart Failure Study Group: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. New England J Med. 1996, 334: 1349-1355. 10.1056/NEJM199605233342101.
Article
CAS
Google Scholar
CIBIS-II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999, 353: 9-13.
Article
Google Scholar
MERIT-HF study group: Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999, 353: 2001-2007.
Article
Google Scholar
Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, Allaf DE, Vítovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Jánosi A, Thorgeirsson G, Dunselman PHJM, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P, for the MERIT-HF Study Group: Effects of controlled-release metoprolol on total mortality, hospitalisations, and well-being in patients with heartfailure: the Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000, 283: 1295-1302. 10.1001/jama.283.10.1295.
Article
PubMed
CAS
Google Scholar
Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL, for the Carvedilol Prospective Randomized Cumulative Survival Study Group: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001, 344: 1651-1658. 10.1056/NEJM200105313442201.
Article
PubMed
CAS
Google Scholar
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GYH, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, on behalf of The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: Developed in collaboration with the Heart Failure Association (HFA) of the ESC. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J. 2012, 33: 1787-1847.
Article
PubMed
Google Scholar
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel): Guidelines for the Prevention, Detection and Management of People With Chronic Heart Failure in Australia. Updated October 2011. 2011, Melbourne: National Heart Foundation of Australia
Google Scholar
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL: 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 2013. [http://circ.ahajournals.org/content/early/2013/06/03/CIR.0b013e31829e8776.citation]
Krum H, Tonkin AM, Currie R, Djundjek R, Johnston CI: Chronic heart failure in Australian general practice: The Cardiac Awareness Survey and Evaluation (CASE) Study. Med J Australia. 2001, 174: 439-444.
PubMed
CAS
Google Scholar
Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J: The EuorHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Eur Heart J. 2003, 24: 464-474. 10.1016/S0195-668X(02)00700-5.
Article
PubMed
CAS
Google Scholar
Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, Sun JL, Yancy CW, Young JB, on behalf of the OPTIMIZE-HF Investigators and Coordinators: Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure). Am J Cardiol. 2008, 102: 1524-1529. 10.1016/j.amjcard.2008.07.045.
Article
PubMed
CAS
Google Scholar
Gjesing A, Schou M, Torp-Pedersen C, Køber L, Gustafsson F, Hildebrandt P, Videbæk L, Wiggers H, Demant M, Charlot M, Gislason GH: Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care. Eur J Heart Fail. 2013, 15: 671-678. 10.1093/eurjhf/hft011.
Article
PubMed
CAS
Google Scholar
Phillips SM, Marton RL, Tofler GH: Barriers to diagnosing and managing heart failure in primary care. MJA. 2004, 181 (2): 78-81.
PubMed
Google Scholar
Stromberg A, Martensson J, Fridlund B, Levin L-A, Karlsson J-E, Dahlstrom U: Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial. Eur Heart J. 2003, 24 (11): 1014-1023. 10.1016/S0195-668X(03)00112-X.
Article
PubMed
CAS
Google Scholar
Jain A, Mills P, Nunn L, Butler J, Luddington L, Ross V, Cliffe P, Ranjadayalan K, Timmis A: Success of a multidisciplinary heart failure clinic for titration and up-titration of key therapeutic agents. Eur J Heart Fail. 2005, 7: 405-410. 10.1016/j.ejheart.2004.09.009.
Article
PubMed
Google Scholar
Driscoll A, Krum H, Wolfe R, Tonkin A: Nurse-led titration of beta-blockers can improve outcomes in chronic heart failure patients in the community. J Card Fail. 2011, 17: 224-230. 10.1016/j.cardfail.2010.10.010.
Article
PubMed
Google Scholar
Rector TS, Kubo SH, Cohn JN: Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993, 71: 1106-1107. 10.1016/0002-9149(93)90582-W.
Article
PubMed
CAS
Google Scholar
Hare DL, Davis CR: Cardiac Depression Scale: validation of a new depression scale for cardiac patients. J Psychosom Res. 1996, 40: 379-386. 10.1016/0022-3999(95)00612-5.
Article
PubMed
CAS
Google Scholar
Charlson ME, Sax FL, MacKenzie CR, Braham RL, Fields SD, Douglas RG: A new method of classifying prognostic co-morbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016/0021-9681(87)90171-8.
Article
PubMed
CAS
Google Scholar